Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Innerspace, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

237 daysmedian FDA review time
319 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K113088HUMMINGBIRD SUBDURAL H900DS (DRAINAGE AND ICP), HUMMINGBIRD Innerspace, Inc.2012-05-021960
K083378SYNERGYInnerspace, Inc.2009-09-293190
K072379MPS OXIPORT AND MPS OXIPORT PLUSInnerspace, Inc.2008-04-292490
K041838MPS (OR MPS-T)Innerspace, Inc.2005-03-012370
K013705ACT III VENTRICULAR CATHETERInnerspace, Inc.2002-09-093050
K013005ACT 11 MP VENTRICULAR CATHETERInnerspace, Inc.2002-03-081830
K010422ACT II ICP MONITORING SYSTEM AND VENTRICULAR CATHETERInnerspace, Inc.2001-06-281360
K003905ACTI-ICP MONITORING SYSTEMInnerspace, Inc.2001-06-151780

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda